Market
MMI pockets $125m to back its robotic microsurgery’s market growth
MMI secured $125 million in Series D funding to expand commercial deployment of its Symani Surgical System, a robotic platform for microsurgery. The capital will support market growth and additional research into the technology, signaling investor confidence in the robotic microsurgery segment.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network